Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Ascendis Pharma A/S changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 172 | 1 | 177 | +6 |
| Shares | 58.4M | 35 | 62.0M | +3.59M (+6.2%) |
| Value | $7.85B | $5.00K | $7.27B | −$582.2M (−7.4%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held Ascendis Pharma A/S at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (24)
Institutions that held Ascendis Pharma A/S at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Point72 Asset Management, L.P. | 112,200 | $15.1M |
| Deep Track Capital, LP | 80,000 | $10.8M |
| Citadel Advisors LLC | 52,026 | $7.00M |
| Bamco Inc | 20,500 | $2.76M |
| Advisors Asset Management, Inc. | 16,251 | $2.19M |
| Ergoteles LLC | 13,165 | $1.77M |
| Schonfeld Strategic Advisors LLC | 12,800 | $1.72M |
| BNP Paribas Arbitrage, SA | 11,191 | $1.51M |
| Gsa Capital Partners LLP | 8,175 | $1.10M |
| Eqis Capital Management, Inc. | 8,113 | $1.09M |
| Rock Creek Group, LP | 4,006 | $487.0K |
| Duality Advisers, LP | 2,526 | $340.0K |
| Dynamic Technology Lab Private Ltd | 1,910 | $257.0K |
| Sumitomo Mitsui Trust Holdings, Inc. | 1,904 | $256.0K |
| Squarepoint Ops LLC | 1,826 | $246.0K |
| Bridgefront Capital, LLC | 1,708 | $230.0K |
| Ground Swell Capital, LLC | 1,699 | $229.0K |
| Centiva Capital, LP | 1,640 | $221.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 195 | $26.0K |
| Chilton Capital Management LLC | 167 | $22.0K |
| Cubist Systematic Strategies, LLC | 110 | $15.0K |
| Lee Financial Co | 69 | $9.00K |
| Proequities, Inc. | 7 | $1.00K |
| EverSource Wealth Advisors, LLC | 10 | $1.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Ascendis Pharma A/S at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Bell Investment Advisors, Inc | 35 | $5.00K |